Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-08
2011-03-08
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252130, C514S254010, C514S319000, C514S422000, C544S141000, C544S372000, C546S205000, C548S518000
Reexamination Certificate
active
07902191
ABSTRACT:
The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.
REFERENCES:
patent: 0 375 297 (1990-06-01), None
patent: 1 494 630 (1967-09-01), None
patent: 276571 (1927-09-01), None
patent: 840 358 (1960-07-01), None
patent: WO 02/076925 (2002-10-01), None
patent: WO 03/064411 (2003-08-01), None
Ferrari, et al., New Series of b-adrenergic blocking agents, Bollettino Chimico Farmaceutico 103(1), 32-6 (1964).
Fujimura, et al., Syntheses and Pharmacological Action of Tetralin Derivatives, Yakugaku Zasshi, 74, 954-6 (1954).
Hancock, et al., Antiobesity Effects of A-331440, a Novel Non-imidazole Histamine H Receptor Antagonist, European J. of Pharm., 487, 183-197 (2004).
Fujimura et al., “Syntheses and pharmacological action of Tetralin derivates,”Yakugaku Zasshi—Journal of the Pharmaceutical Society of Japan, No. 74, pp. 954-956, 1954.
Beavers Lisa Selsam
Gadski Robert Alan
Hipskind Philip Arthur
Jesudason Cynthia Darshini
Lindsley Craig William
Eli Lilly and Company
Leeser Erich A
Wilson James O
Wood Dan L.
LandOfFree
Histamine H3 receptor antagonists, preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Histamine H3 receptor antagonists, preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histamine H3 receptor antagonists, preparation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672010